Beth Israel Deaconess Medical Center, Boston, U.S.
Eptifibatide during percutaneous coronary stenting is feasible and safe
Published in Medical Device Law Weekly, August 27th, 2006
According to recent research from the United States, "Distal embolization of thrombotic debris may occur during and after percutaneous coronary intervention (PCI) for acute coronary syndromes. This may lead to impaired microvascular perfusion, myocardial infarction and increased morbidity and mortality. In vitro studies suggest that high local concentrations of a glycoprotein IIb/IIIa inhibitor may be effective in disaggregating thrombus and thereby prevent microvascular compromise. We hypothesized that IC...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
More Articles from Medical Device Law Weekly
- Aomori Municipal Hospital, Aomori, Japan
Coronary artery bypass grafting using an abdominal artery as an inflow is described - BioMag
BioMag files application for a multi-assay diagnostic system designed for blood banks - Biosite
Biosite notes 45% increase in sales of cardiovascular products - Business Update
Care Improvement Plus opens first assessment center for Medicare beneficiaries with chronic illness - Patents
Med-Vantage files for patent to protect software for comparing physician quality and costs - University of Tubingen, Germany
Statin therapy reduces morbidity and mortality after chronic obstructive pulmonary disease - More from this issue of Medical Device Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
